INTERACTIONS OF A NEW ANTI-TUMOR AGENT,1,4-DIHYDROXY-5,8-BIS[[2-[(2-HYDROXYETHYL)AMINO]-ETHYL]AMINO]-9,10-ANTHRACENEDIONE, WITH NUCLEIC-ACIDS
INTERACTIONS OF A NEW ANTI-TUMOR AGENT,1,4-DIHYDROXY-5,8-BIS[[2-[(2-HYDROXYETHYL)AMINO]-ETHYL]AMINO]-9,10-ANTHRACENEDIONE, WITH NUCLEIC-ACIDS
复制标题
DOI:
10.1016/0006-2952(81)90083-6
复制
发表时间:
1981-01-01
影响因子:
5.8
通讯作者:
MELAMED, MR
中科院分区:
文献类型:
--
作者:
KAPUSCINSKI, J;DARZYNKIEWICZ, Z;MELAMED, MR
1,4-Dihydroxyl-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione (DHAQ), a new antitumor drug (NSC 279836), suppressed cell progression [of mouse Friend leukemia cells] at the G2 phase in vitro at concentrations of 1-10 ng/ml. Cells blocked in G2 contained increased amounts of RNA. The drug bound to DNA and RNA in the nuclear chromatin with a prefrence for the nucleolus and to RNA in the cytoplasm of cells in situ. Spectroscopic evidence indicated that DHAQ interacts by intercalation with natural [calf thymus DNA and wheat germ RNA] and synthetic nucleic acids, although electrostatic interactions also play a part in the binding. All A and B structure nucleic acids intercalated DHAQ, although there was no clear base specificity; interactions with polymers containing only A-T base pairs were somewhat weaker than with other polymers and alternating polymers exhibited stronger affinity than did homopolymer pairs. Electrophoretic dye titration with SV40 DNA provided additional proof that DHAQ binds to DNA by intercalation. The intrinsic association constant of the drug (Ki) was 1.8 .times. 106 M-1, its binding site size (n) was 5 nucleotides and the unwinding angle (.vphi.) was 26.5.degree.. Because DHAQ precipitated single-stranded polymers, it is possible that the drug interacted electrostatically with the anionic exterior of single-stranded nucleic acids with subsequent stacking. The pharamacological effect of DHAQ may be related to drug intercalation into double-stranded nucleic acids which may impair DNA transcription and RNA processing.